Skip to content

Study · Animal study (in vivo) · 1977

1 result

Serum thymic factor and the neuromuscular transmission.

Lasmoles F, Kelemen N, Milhaud G

Biomedicine / [publiee pour l'A.A.I.C.I.G.]1 Dec 1977

PMID203348 (opens in a new tab)PepBankPUB-00203348
Publisher pageAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In an in vivo electromyographic assay, serum thymic factor did not modify the muscle tetanus pattern.

    In plain wordsIn animals, serum thymic factor did not change the muscle tetanus pattern.

    Peptide
    Thymulin (serum thymic factor)
    Outcome
    No significant changeMuscle tetanus pattern
    Study

    n: not reported in source

    Outcome group
    Muscle injury and repair · Musculoskeletal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    As no modification of muscle tetanus pattern was detected
    1 context sentence
    Summary · context
    The effect of Serum Thymic Factor (FTS) on neuromuscular transmission has been studied in vivo by electromyographic assay.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.